Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease
Go back to Alnylam Highlights Progress with Neuroscience Programs at AAIC 2026, Showcasing Potential of RNAi in Neurological Disease| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 266.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.99 | 52 Week High | $109.10 | |||
| Open | $266.99 | 52 Week Low | $31.38 | |||
| Day High | $266.99 | P/E | N/A | |||
| Day Low | $266.99 | EPS | $-1.45 | |||
| Volume | 1,633 | |||||
